The main idea here is how often patients stop a new medication within the first six months. In real-world use, many people have trouble sticking with a new therapy because of side effects, not feeling an immediate benefit, cost, or a complicated dosing schedule. This pattern of substantial early drop-off is common, so a figure around 80% reflects that heavy attrition during the first half year. It highlights why proactive support after starting a medication is crucial—monitoring side effects, clarifying expected benefits, simplifying the regimen, and addressing barriers to ongoing use. While some patients do remain on treatment beyond six months, the overall tendency is for a large majority to discontinue early, which is why 80% is the best match among the options.

Hazard analysis identifies what could cause harm. It’s about spotting potential hazards and hazardous situations related to the device, its use, labeling, and foreseeable misuse—without judging how likely or how severe those harms are yet. Risk assessment uses that list to judge how serious and how likely each hazard is. It evaluates the severity of the harm if it occurs and the probability or frequency of its occurrence, often considering exposure and detectability. This step yields a risk level to guide whether controls are needed and how effective those controls are, including assessing residual risk after applying safety measures. For example, in a medical device, hazard analysis might flag risks like electrical overstimulation, insulation failure, lead fracture, or infection. The risk assessment would then assign levels for how severe the harm could be and how likely each hazard is, helping determine appropriate design changes, labeling, or protective measures to bring overall risk to an acceptable level.

Sterile technique reduces the risk of infection by keeping the surgical field free of bacteria, which is the direct way it protects implant safety. In implant procedures, an infection can disrupt tissue healing around the device, lead to implant loosening or failure, and even cause serious systemic illness. Bacteria can form a biofilm on implant surfaces, making infections hard to treat and compromising the device’s function. By ensuring skin antisepsis, sterile gloves and instruments, proper draping, and minimal contamination, the chance of introducing pathogens is minimized, preserving a safe environment for the implant to be placed. While good healing, device longevity, and battery performance are important, they are not guaranteed by sterility alone; they depend on many factors beyond preventing infection. The key impact of sterile technique is preventing infection, thereby directly supporting implant safety.

Intention-to-treat analysis includes every participant as originally randomized, regardless of whether they adhered to the treatment or completed the study. This preserves the benefits of randomization and mirrors real-world practice, where not everyone follows the protocol exactly. It avoids bias that can come from excluding nonadherent participants and tends to provide a more conservative estimate of a treatment’s effectiveness. In contrast, analyses that exclude noncompliant participants or only analyze those who completed the protocol can overestimate effects because the groups may no longer be comparable. Post-hoc analyses are exploratory and not the same as the original randomized comparison. When using intention-to-treat, researchers still need to address missing data appropriately to avoid introducing new biases.

The main idea here is how the device’s energy is replenished and how that affects what the patient has to do over time. A rechargeable SNM system uses a battery that you replenish with an external charger. The patient will need to charge the implanted generator regularly to keep therapy going, so maintenance involves charging sessions rather than surgeries. A non-rechargeable SNM has a battery inside that isn’t recharged. When that battery runs out, the generator powers down and must be surgically replaced with a new one to restore therapy. This distinction drives two very different patient experiences: regular charging versus periodic surgical replacements. That’s why this option fits best. The statement reflects the practical difference in upkeep between the two types. The other choices are off because rechargeable devices are not implanted externally, non-rechargeable devices do require maintenance (replacement surgeries), and there is a difference in maintenance between the two.